Affordable Access

A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.

Authors
Type
Published Article
Journal
American journal of hypertension
Publication Date
Volume
19
Issue
1
Pages
104–112
Identifiers
PMID: 16461201
Source
Medline
License
Unknown

Abstract

Telmisartan 80 mg was consistently more effective than ramipril 10 mg in reducing both DBP and SBP during the last 6 h of the dosing interval, a measure of the early morning period when patients are at greatest risk of life-threatening cardiovascular and cerebrovascular events. Telmisartan 80 mg was also more effective than ramipril 10 mg in reducing BP throughout the entire 24-h dosing interval. Both drugs were well tolerated.

Statistics

Seen <100 times